Stockreport

Revvity: Close To A Buy, Not Quite There [Seeking Alpha]

Revvity, Inc.  (RVTY) 
PDF Signals software a standout: high-teens growth, SaaS ARR +40%. China immunodiagnostics and NIH funding remain key drags. RVTY valuation is stretched. Hold, watch fo [Read more]